Come up with a name for your new list and we'll add to it:
Bioenvision was acquired by
Genzyme on October 12, 2007.
Bioenvision is a biopharmaceutical company engaged in the development and distribution of drugs to treat cancer. Bioenvision has the opportunity to emerge into an oncology-focused pharmaceutical compa…